-
Featured Authors
-
Archives
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Latest From Biotech Now
Prior User Rights and Trade Secrets
By Joe Allen, President, Allen and Associates One theme of the day is the cloud of uncertainity overhanging the US patent system. This was underscored in the Prior User Rights and Trade Secrets session at the 2012 BIO International Convention as well. The new prior user rights defense which came into effect with enactment of the America Invents Act (AIA) was very differently viewed by the small biotech company perspective given by Mary Ann Dillahunty (Oncolytics Read More >
BIO Official Blogger Roundup
Want to know what’s happening at the 2012 BIO International Convention? Find out from our BIO Official Bloggers! Enterprise, Advanced Education, and Stephen Khan, Genome Alberta My PET Bottle, Genome Alberta Research Partnerships Catalyze Economic Growth, LillyPad BIO 2012: Patients and PDUFA, Campaign for Modern Medicine Scientific American Worldview 4th edition now available #bio2012, Biotech Blog BIO 2012 Day 2: Justices Ponder Hot Tubbing, Patent Baristas Docs at BIO: IP Challenges to Personalized Medicine & Read More >
Recent Developments in Patentability: Prometheus and Myriad
By Joe Allen, President, Allen and Associates Recent Developments in Patentability: Prometheus and Myriad at the 2012 BIO International Convention was a very lively panel discussion on two cases that have set the life science industry on edge. The discussion presented an appropriate diversity of views as experts struggle with how broadly these cases should be interpreted. Briefly, the unanimous decision by the Supreme Court overtuning a decision upholding the Prometheus patents by the Court Read More >
BIO Official Blogger Roundup
Want to know what’s happening at the 2012 BIO International Convention? Find out from our BIO Official Bloggers! Denmark leads the world in its pro-research attitude #bio2012, Biotech Blog Bioentrepreneurship Bootcamp signing at #bio2012, Biotech Blog Welcome to BIO 2012!, Campaign for Modern Medicine Greetings from BIO 2012!, The Cross-Border Biotech Blog BIORadio Lands in Boston, Genomics Blog Kicking off #BIO2012, LillyPad Research Partnerships Catalyze Economic Growth, LillyPad The BIO Official Bloggers Take Boston, Patent Baristas BIO Day 1: China, IP and Savings Read More >
From Bench to Bedside in a Bioeconomy
By Joe Allen, President, Allen and Associates It’s a sign of a well crafted program when the closing panel reinforces the opening speaker. Boston University President Robert Brown kicked off the afternoon at the Translational Research Forum at the 2012 BIO International Convention by showing how the old linear model of product development crafted after World War II no longer applies. The closing industry panel aptly remarked that a struggling economy has brought the public and private Read More >
